Small-Cap REIT ETF ...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$13.27 0.26 | 2.00%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -20.85M | -22.76M | 15.14M | -45.14M |
| Operating Gains/Losses | -252.00K | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -585.00K | -29.00K | -990.00K | 656.00K |
| (Decrease) Increase In Other Current Liabilities | 635.00K | 277.00K | -2.14M | -2.28M |
| (Increase) Decrease In Other Working Capital | -2.81M | -43.00K | -25.37M | 28.20M |
| Other Non-Cash Items | 1.93M | 2.40M | 1.37M | 2.72M |
| Net Cash From Continuing Operations | -21.63M | -19.90M | -10.70M | -13.73M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -21.63M | -19.90M | -10.70M | -13.73M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 128.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 30.95M | 54.05M | 53.49M | 59.75M |
| Purchases of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | -41.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -56.73M | -48.07M | -54.67M | -50.26M |
| Other Cash from Investing Activities | 252.00K | -3.00K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -25.53M | 5.98M | -1.06M | 9.44M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 98.20M | 14.02M | 823.00K | 1.92M |
| Repayment of Long-Term Debt | -32.00K | -78.00K | -353.00K | -762.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 98.17M | 13.94M | 470.00K | 1.16M |
| Effect of Exchange Rate Changes | -1.00K | 13.00K | 20.00K | 73.00K |
| Net Change in Cash & Cash Equivalents | 51.01M | 40.00K | -11.27M | -3.05M |
Portfolios with ACAD
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserDividend Portfolio
- UserWatch
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
Latest ACAD Headlines from TheStreet
- ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Laggard 04.29.13 | 05:04 pm
- 2 Biotech Stocks Soaring on Big Volume 04.22.13 | 02:04 pm
- ACADIA Stock Falls On Unusually High Volume (ACAD) 04.12.13 | 10:04 am
- Cramer's 6 Stocks in 60 Seconds: UA ADBE FTNT ACAD CELG RLGY (Update 1) 04.11.13 | 05:04 pm
- Stocks Ramp-Up on Encouraging Jobs Report 04.11.13 | 04:04 pm
- 5 Stocks Under $10 Set to Soar Higher 04.11.13 | 02:04 pm
- Acadia Plans Early FDA Filing Of Parkinson's Drug 04.11.13 | 07:04 am
- 'Mad Money' Lightning Round: Acadia Pharmaceuticals Is a Buy 04.05.13 | 06:04 am
- TheStreet Ratings Top 10 Rating Changes 04.01.13 | 11:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 03.28.13 | 05:03 am
Press Releases for ACAD
- Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick - PR Newswire 04.08.13 | 08:04 am
- ACADIA Announces Presentation Of Data From Its Pivotal Phase III Parkinson’s Disease Psychosis Study With Pimavanserin At The American Academy Of Neurology Annual Meeting - Business Wire 03.20.13 | 10:03 pm
- ACADIA Pharmaceuticals To Present At The 25th Annual ROTH Conference On March 19, 2013 - Business Wire 03.13.13 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012 - Business Wire 03.12.13 | 04:03 pm
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2012 Financial Results On March 12, 2013 - Business Wire 03.05.13 | 09:03 am
- ACADIA Pharmaceuticals To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4, 2013 - Business Wire 02.25.13 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference On February 12, 2013 - Business Wire 02.05.13 | 09:02 am
- ACADIA Pharmaceuticals Announces Election Of Stephen R. Biggar To Its Board Of Directors - Business Wire 01.22.13 | 09:01 am
- ACADIA Pharmaceuticals To Receive Funding From Fast Forward And EMD Serono For Multiple Sclerosis Program - Business Wire 12.20.12 | 08:12 am
- ACADIA Pharmaceuticals To Present At The Oppenheimer 23rd Annual Healthcare Conference Today, December 12, 2012 - Business Wire 12.12.12 | 12:12 pm
Partner Headlines for ACAD
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Mid-Day Market Update: Herman Miller Surges On Upbeat Earnings, Scholastic Falls - Benzinga 03.21.13 | 01:03 pm
- Pre-Market Most Active for Mar 21, 2013 : NOK, ORCL, SNY, BAC, BBRY, TOT, ACAD, CWT, CSCO, AWC, QQQ, ZNGA - NASDAQ 03.21.13 | 12:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- After Hours Most Active for Nov 27, 2012 : ACAD, GMCR, CIG, DISH, EFII, NOK, T, BAC, JEF, MSFT, DTV, HAL - NASDAQ 11.27.12 | 09:11 pm
- Pre-Market Most Active for Nov 27, 2012 : ACAD, RAH, BAC, FB, NOK, SNE, GLW, SID, QQQ, AAPL, EBAY, ZNGA - NASDAQ 11.27.12 | 01:11 pm
